Constitutive Association of BRCA1 and c-Abl and Its ATM-Dependent Disruption after Irradiation

ABSTRACT BRCA1 plays an important role in mechanisms of response to double-strand breaks, participating in genome surveillance, DNA repair, and cell cycle checkpoint arrests. Here, we identify a constitutive BRCA1-c-Abl complex and provide evidence for a direct interaction between the PXXP motif in the C terminus of BRCA1 and the SH3 domain of c-Abl. Following exposure to ionizing radiation (IR), the BRCA1-c-Abl complex is disrupted in an ATM-dependent manner, which correlates temporally with ATM-dependent phosphorylation of BRCA1 and ATM-dependent enhancement of the tyrosine kinase activity of c-Abl. The BRCA1-c-Abl interaction is affected by radiation-induced modification to both BRCA1 and c-Abl. We show that the C terminus of BRCA1 is phosphorylated by c-Abl in vitro. In vivo, BRCA1 is phosphorylated at tyrosine residues in an ATM-dependent, radiation-dependent manner. Tyrosine phosphorylation of BRCA1, however, is not required for the disruption of the BRCA1-c-Abl complex. BRCA1-mutated cells exhibit constitutively high c-Abl kinase activity that is not further increased on exposure to IR. We suggest a model in which BRCA1 acts in concert with ATM to regulate c-Abl tyrosine kinase activity.

[1]  R. Fishel,et al.  BCR/ABL regulates mammalian RecA homologs, resulting in drug resistance. , 2001, Molecular cell.

[2]  J. Parvin,et al.  Redistribution of BRCA1 among Four Different Protein Complexes following Replication Blockage* , 2001, The Journal of Biological Chemistry.

[3]  Rachel E. Klevit,et al.  Structure of a BRCA1–BARD1 heterodimeric RING–RING complex , 2001, Nature Structural Biology.

[4]  P. Opolon,et al.  BRCA1 carries tumor suppressor activity distinct from that of p53 and p21 , 2001, Cancer Gene Therapy.

[5]  J. Glover,et al.  Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1 , 2001, Nature Structural Biology.

[6]  Giulio Superti-Furga,et al.  Dynamic Coupling between the SH2 and SH3 Domains of c-Src and Hck Underlies Their Inactivation by C-Terminal Tyrosine Phosphorylation , 2001, Cell.

[7]  D. Sgroi,et al.  BACH1, a Novel Helicase-like Protein, Interacts Directly with BRCA1 and Contributes to Its DNA Repair Function , 2001, Cell.

[8]  S. Ganesan,et al.  Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. , 2001, Molecular cell.

[9]  S. Elledge,et al.  Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. , 2000, Genes & development.

[10]  Jean Y. J. Wang.  Regulation of cell death by the Abl tyrosine kinase , 2000, Oncogene.

[11]  M. Sternberg,et al.  The BRCA1 C-terminal domain: structure and function. , 2000, Mutation research.

[12]  C. Deng,et al.  Roles of BRCA1 and its interacting proteins , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[13]  Y. Shiloh,et al.  Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response , 2000, Nature.

[14]  M. Gatei,et al.  Role for ATM in DNA damage-induced phosphorylation of BRCA1. , 2000, Cancer research.

[15]  S. Elledge,et al.  BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. , 2000, Genes & development.

[16]  Jong-Soo Lee,et al.  hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response , 2000, Nature.

[17]  M. Macleod,et al.  Regulation of BRCA1 Expression by the Rb-E2F Pathway* , 2000, The Journal of Biological Chemistry.

[18]  S. Elledge,et al.  Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. , 1999, Science.

[19]  J. Petrini,et al.  The Mre11-Rad50-Xrs2 Protein Complex Facilitates Homologous Recombination-Based Double-Strand Break Repair inSaccharomyces cerevisiae , 1999, Molecular and Cellular Biology.

[20]  E. Liu,et al.  BRCA1-associated growth arrest is RB-dependent. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[21]  C. Wang,et al.  Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. , 1999, Science.

[22]  F. Christians,et al.  Induction of GADD45 and JNK/SAPK-Dependent Apoptosis following Inducible Expression of BRCA1 , 1999, Cell.

[23]  D. Livingston,et al.  BRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway. , 1999, Cancer research.

[24]  R. Weichselbaum,et al.  Determination of cell fate by c-Abl activation in the response to DNA damage , 1998, Oncogene.

[25]  F. Couch,et al.  Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. , 1998, Molecular cell.

[26]  J. Minna,et al.  Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier. , 1998, Cancer research.

[27]  G. Superti-Furga,et al.  An intramolecular SH3-domain interaction regulates c-Abl activity , 1998, Nature Genetics.

[28]  Hongbing Zhang,et al.  BRCA1, BRCA2, and DNA Damage Response: Collision or Collusion? , 1998, Cell.

[29]  P. Sung,et al.  Regulation of Rad51 Function by c-Abl in Response to DNA Damage* , 1998, The Journal of Biological Chemistry.

[30]  Shengfang Jin,et al.  Binding of Ku and c-Abl at the Kinase Homology Region of DNA-dependent Protein Kinase Catalytic Subunit* , 1997, The Journal of Biological Chemistry.

[31]  Ralph Scully,et al.  Dynamic Changes of BRCA1 Subnuclear Location and Phosphorylation State Are Initiated by DNA Damage , 1997, Cell.

[32]  Huichen Wang,et al.  BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases , 1997, Oncogene.

[33]  H. Ruffner,et al.  BRCA1 is a cell cycle-regulated nuclear phosphoprotein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[34]  B. Weber,et al.  Relationship of p215BRCA1 to tyrosine kinase signaling pathways and the cell cycle in normal and transformed cells , 1997, Oncogene.

[35]  D. Baltimore,et al.  Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation , 1997, Nature.

[36]  Y. Shiloh,et al.  Interaction between ATM protein and c-Abl in response to DNA damage , 1997, Nature.

[37]  Yonghong Xiao,et al.  Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells , 1997, Cell.

[38]  J. Mornon,et al.  From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair , 1997, FEBS letters.

[39]  R. Weichselbaum,et al.  Activation of the c-Abl tyrosine kinase in the stress response to DMA-damaging agents , 1995, Nature.

[40]  Olnes Mi,et al.  Isolation of nuclear extracts from fragile cells: a simplified procedure applied to thymocytes. , 1994 .

[41]  D. Baltimore,et al.  Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase , 1994, Molecular and cellular biology.

[42]  J. Wang,et al.  Tyrosine phosphorylation of mammalian RNA polymerase II carboxyl-terminal domain. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[43]  P. J. Welch,et al.  A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle , 1993, Cell.

[44]  D. Easton,et al.  Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. , 1993, American journal of human genetics.

[45]  Peggy J. Farnham,et al.  Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties , 1992, Cell.

[46]  R. Bronson,et al.  Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene , 1991, Cell.

[47]  D. Baltimore,et al.  The noncatalytic src homology region 2 segment of abl tyrosine kinase binds to tyrosine-phosphorylated cellular proteins with high affinity. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[48]  M. Gatei,et al.  Ataxia Telangiectasia Mutated (ATM) Kinase and ATM and Rad3 Related Kinase Mediate Phosphorylation of Brca1 at Distinct and Overlapping Sites IN VIVO ASSESSMENT USING PHOSPHO-SPECIFIC ANTIBODIES* , 2001 .

[49]  Y. Shaul.  c-Abl: activation and nuclear targets , 2000, Cell Death and Differentiation.

[50]  K. Kinzler,et al.  Cancer-susceptibility genes. Gatekeepers and caretakers. , 1997, Nature.

[51]  R. Kurl,et al.  Isolation of nuclear extracts from fragile cells: a simplified procedure applied to thymocytes. , 1994, BioTechniques.

[52]  K. Umezawa,et al.  Use of erbstatin as protein-tyrosine kinase inhibitor. , 1991, Methods in enzymology.

[53]  G. Daley,et al.  Implicating the bcr/abl gene in the pathogenesis of Philadelphia chromosome-positive human leukemia. , 1991, Advances in cancer research.